{"id":124,"date":"2012-10-07T14:04:44","date_gmt":"2012-10-07T14:04:44","guid":{"rendered":"http:\/\/iatdmct.com\/?page_id=124"},"modified":"2013-09-14T22:05:15","modified_gmt":"2013-09-14T22:05:15","slug":"plenary-speakers","status":"publish","type":"page","link":"http:\/\/iatdmct.com\/?page_id=124","title":{"rendered":"Plenary Speakers"},"content":{"rendered":"

“Bio-Nano-Chip” Technologies for Point of Care Testing of Drugs and Metabolites<\/span><\/p>\n

John T. McDevitt, Ph.D.<\/span><\/p>\n

Monday, September 23, 0915-1015<\/span><\/p>\n

\n

\"JohnJohn T. McDevitt is the Brown-Wiess Professor of Chemistry and Bioengineering at Rice University and is a pioneer in the development of \u201cprogrammable bio-nano-chip” technologies. Since joining Rice in 2009, McDevitt\u2019s group has focused primarily on development of portable diagnostic devices that have potential to replace high-cost, lab-based, time-consuming diagnostic tests for both resource scarce settings where traditional laboratory measurements are not practical as well as for developed countries that are seeking to reduce health care costs. McDevitt’s recent research has been supported by major programs funded by the National Institute of Dental and Craniofacial Research (NIDCR) division of the National Institutes of Health (NIH), the Bill and Melinda Gates Foundation, Cancer Prevention Research Institute of Texas (CPRIT), the National Aeronautics and Space Administration (NASA) and the United Kingdom\u2019s Home Office Scientific Development Branch. McDevitt and his team have written more than 170 peer-reviewed scientific manuscripts and have contributed to more than 150 patents and patent applications. This work was recognized with the \u201cBest of What’s New Award\u201d in the Medical Device Category for 2008 by Popular Science as well as for the \u201cBest Scientific Advances Award\u201d in 1998 by the Science Coalition. Dr. McDevitt\u2019s individual honors include the Presidential Young Investigator Award, the 2010 California Polytechnic Distinguished Alumni Award and the Exxon Education Award. McDevitt now serves as the Principal Investigator for 6 major clinical trials and 2 clinical pilot studies all involving the programmable bio-nano-chip. Through these clinical efforts mini-sensor ensembles are being developed for major diseases in the areas of cardiac heart disease, trauma, drugs of abuse, oral cancer, ovarian cancer and prostate cancer. With CPRIT funding McDevitt has recently established the “Texas Cancer Diagnostics Pipeline” and serves at the Director for the newly formed “Early Disease Detection Gulf Coast Consortium Cluster” thereby creating a network of over 100 clinical researchers devoted to next generation of affordable diagnostics. McDevitt serves as the Scientific Founder for several companies in areas related to medical microdevice technologies.<\/span><\/p>\n

<\/p>\n

Objectives:<\/div>\n